The single nucleotide polymorphism state of ERCC1, a DNA damage repair gene, was reported to be a useful predictive genetic biomarker for chemoradiation treatment outcomes in ESCC [31]. This evidence concerns the gene ERCC1 and esophageal squamous cell carcinoma.